Save your place

Sign in to WhoBought

Please try again later.

AstraZeneca PLC (AZN) institutional ownership

Latest close $169.26 Jul 24, 2026
Market cap$284.3B 52-week range SectorHealthcare
Funds holding · Q1 2026
1,305
reported AZN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
1,278 buyers · 27 sellers

AstraZeneca PLC (AZN) price and institutional activity

Dates

Q1 2026

$119.5B bought by 1278 investors
Vanguard$12.7BInvestor AB$8.4B +1,276 more
$4.6M sold by 27 investors
L & S Advisors Inc-$3.0MMay Hill Capital, LLC-$535K +25 more
Bought Sold Totals per quarter; hover a bar for the names.

AstraZeneca PLC (AZN) institutional activity · 1,305

Investor Type Est. change Change Δ Own Date
Vanguard · New +$12.7B
Change +78.1M Date Q1 2026
Vanguard New· Q1 2026 +$12.7B +78.1M Q1 2026
Investor AB · New +$8.4B
Change +51.6M Date Q1 2026
Investor AB New· Q1 2026 +$8.4B +51.6M Q1 2026
Capital International Investors · New +$5.6B
Change +34.4M Date Q1 2026
Capital International Investors New· Q1 2026 +$5.6B +34.4M Q1 2026
FMR LLC · New +$4.8B
Change +29.6M Date Q1 2026
FMR LLC New· Q1 2026 +$4.8B +29.6M Q1 2026
Capital World Investors · New +$4.6B
Change +28.3M Date Q1 2026
Capital World Investors New· Q1 2026 +$4.6B +28.3M Q1 2026
Legal & General · New +$4.2B
Change +25.8M Date Q1 2026
Legal & General New· Q1 2026 +$4.2B +25.8M Q1 2026
Wellington Management Group LLP · New +$3.9B
Change +23.8M Date Q1 2026
Wellington Management Group LLP New· Q1 2026 +$3.9B +23.8M Q1 2026
T. Rowe Price Associates · New +$3.2B
Change +19.5M Date Q1 2026
T. Rowe Price Associates New· Q1 2026 +$3.2B +19.5M Q1 2026
Bank of America Corp · New +$3.1B
Change +19.1M Date Q1 2026
Bank of America Corp New· Q1 2026 +$3.1B +19.1M Q1 2026
JPMorgan Chase & Co · New +$3.0B
Change +18.6M Date Q1 2026
JPMorgan Chase & Co New· Q1 2026 +$3.0B +18.6M Q1 2026
Primecap Management Co · New +$3.0B
Change +18.2M Date Q1 2026
Primecap Management Co New· Q1 2026 +$3.0B +18.2M Q1 2026
Amundi · New +$2.5B
Change +15.4M Date Q1 2026
Amundi New· Q1 2026 +$2.5B +15.4M Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main · New +$2.1B
Change +12.9M Date Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main New· Q1 2026 +$2.1B +12.9M Q1 2026
Deutsche Bank AG · New +$2.0B
Change +12.1M Date Q1 2026
Deutsche Bank AG New· Q1 2026 +$2.0B +12.1M Q1 2026
Janus Henderson Group PLC · New +$1.9B
Change +11.9M Date Q1 2026
Janus Henderson Group PLC New· Q1 2026 +$1.9B +11.9M Q1 2026
Data through Q1 2026 · filed Q1 2026
15 of 1305

Famous investor activity in AstraZeneca PLC (AZN)

AstraZeneca PLC (AZN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Sharma Mani · Officer Grant (A) $381
Price $190.43 Qty 2 Owned 19K ΔOwn 0.0% Trade date Jul 6, 2026 Filed date Jul 8, 2026
Sharma Mani Officer Grant (A) $190.43 2 $381 19K 0.0% Jul 6, 2026 Jul 8, 2026
Sharma Mani · Officer Grant (A) $180
Price $179.75 Qty 1 Owned 19K Trade date Jun 8, 2026 Filed date Jun 16, 2026
Sharma Mani Officer Grant (A) $179.75 1 $180 19K Jun 8, 2026 Jun 16, 2026
Sharma Mani · Officer Sell −$2.2M
Price $185.78 Qty −12K Owned 19K Trade date May 20, 2026 Filed date May 22, 2026
Sharma Mani Officer Sell $185.78 −12K −$2.2M 19K May 20, 2026 May 22, 2026
Sharma Mani · Officer Grant (A) $186
Price $186.28 Qty 1 Owned 31K Trade date May 6, 2026 Filed date May 8, 2026
Sharma Mani Officer Grant (A) $186.28 1 $186 31K May 6, 2026 May 8, 2026
Sharma Mani · Officer Grant (A) $196
Price $196.03 Qty 1 Owned 31K Trade date Apr 7, 2026 Filed date May 8, 2026
Sharma Mani Officer Grant (A) $196.03 1 $196 31K Apr 7, 2026 May 8, 2026
5 of 5

AstraZeneca PLC (AZN) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 140.3M
% of shares outstanding 9.1% Filing date Jan 24, 2024
BlackRock Inc. 140.3M 9.1% Jan 24, 2024
Vanguard Capital Management LLC 78.0M
% of shares outstanding 5.0% Filing date Apr 28, 2026
Vanguard Capital Management LLC 78.0M 5.0% Apr 28, 2026
Wellington Management Group LLP 65.5M
% of shares outstanding 4.2% Filing date Feb 4, 2022
Wellington Management Group LLP 65.5M 4.2% Feb 4, 2022
3 of 3

AstraZeneca PLC (AZN) ownership FAQ

Who owns AZN?

1,305 reporting institutions disclosed AZN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.